Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI vs FOLFOX6 in Metastatic Colorectal Cancer
NCT00003260Phase 3Unknown
- Sponsor
- GERCOR
- Start
- Jan 1998
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of irinotecan, oxaliplatin in colorectal cancer (CRC), sponsored by GERCOR. Status: unknown.
02
Drugs
irinotecanoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00003260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003260.